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ABSTRACT 
Objective: Nateglinide is a commonly used oral hypoglycemic, biopharmaceutical classification system Class II drug, which shows relatively poor 
water solubility and variable bioavailability. The objective of the present investigation was to develop the binary and ternary solid dispersions of 
nateglinide for improved solubility and dissolution. 
Methods: Nateglinide solid dispersions were prepared by a common solvent evaporation method. Polymers like soluplus, kolliphor P188, sylloid 
244FP, gelucire 48/16, affinisol (HPMCAS), HPβCD, βCD were used in different combinations. The physicochemical characterization of the 
optimized ternary dispersion was studied by using FT-IR, DSC, and PXRD. Solubility and dissolution behavior of all dispersions were studied.  
Result: From all prepared ternary solid dispersions, nateglinide dissolution was significantly faster than pure nateglinide. With ternary solid 
dispersion of NTG, soluplus and kolliphor P188 there was a big improvement in solubility and dissolution. This combination enhanced the solubility 
of NTG by 23 folds. Another ternary dispersion of NTG with soluplus and gelucire 48/16 enhanced solubility by 25 fold. 
Conclusion: Ternary solid dispersion found superior over binary dispersions. For the ternary dispersions, showing the best solubility, tablets were 
prepared. Dissolution and drug release from the formulated tablet was as good as a marketed product. 
Keywords: Nateglinide, Solid dispersion, Dissolution, Solubility enhancement 
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INTRODUCTION 
Enhancement of the solubility of the poorly water-soluble drug is 
one of the most challenging issues in the pharmaceutical industry. 
Limited drug Dissolution and bioavailability depend on its solubility 
and permeability [1]. Amorphous solid dispersion has been proved 
as an effective method to enhance the solubility and dissolution 
behavior of many BCS II class drugs [2]. Nateglinide is an oral 
hypoglycemic agent used in the treatment of type II diabetes 
mellitus (non-insulin-dependent diabetes mellitus, NIDDM). 
Nateglinide is a non-sulfonylurea drug, belonging to BCS class II, low 
solubility and high permeability [3].  
NTG is an amino-acid derivative; it stimulates insulin secretion from 
β-cells of the pancreas through inhibition of potassium-ATP 
channels. Thereby reduces blood glucose levels. NTG immediately 
gets absorbed from the gastrointestinal tract and eliminated through 
plasma. NTG has a half-life of about 1.5 h [4]. Nateglinide is the most 
effective antidiabetic drug; lipophilic, belongs to family meglitinide, 
recommended in 60 mg or 120 mg dose. It has very poor water 
solubility 0.061 mg/ml. Solubility is the main obstacle to prepare an 
oral dosage form of nateglinide. Studies say that NTG exhibits pH-
dependent solubility and variable bioavailability [5].  
Nateglinide can be used as monotherapy or in combination with 
other hypoglycemic agents. NTG is an elegant, flexible and effective 
treatment option to reduce mealtime glucose in patients with type 2 
diabetes [6]. Vasanti Suvarna et al. have successfully prepared 
ternary solid dispersion of NTG with HP–β–CD and L-Arginine for 
Solubility and Dissolution Enhancement. The solubility of a drug is a 
critical parameter to enhance the oral bioavailability of drugs like 
NTG. Solubility and bioavailability of nateglinide have been 
enhanced previously by using different methods. In our study, we 
have used new combinations of polymers. The main objective of this 
work was to develop a new ternary and binary solid dispersion 
formulation to enhance the solubility of nateglinide. Preparation of 
polymer-based amorphous solid dispersions (ASD) has been widely 
used as a strategy to improve the solubility of poorly water-soluble 
drugs. 
The literature reveals that the solubility of NTG is less at acidic pH, 
while more in alkaline pH. pH-dependent solubility is a major 
concern while designing NTG into the dosage form. As per the 
previous studies nateglinide proved to have good solubility with 
alkalizes like Na2CO3, NaCO3, and NaOH. For the preparation of 
amorphous solid dispersion with a drug like NTG, one must be very 
selective in the choice of polymers [7].  
Soluplus is polyvinyl caprolactam polyvinyl acetate-polyethylene 
glycol graft copolymer. It is an outstanding matrix polymer and 
enhances solubility dramatically. Soluplus is unique in that it is an 
amphiphilic i.e. it can enhance the solubility of both hydrophilic and 
lipophilic drug molecules. Soluplus has been found to have an excellent 
solubilizing efficiency of the BCS class II drugs. It can be used for 
preparing immediate-release formulations of a poorly water-soluble 
BCS class II drug. Soluplus is an interesting polymer, acts as a matrix 
polymer for superior performance in forming solid solutions and an 
active solubilizer through micelle formation in water [8, 9]. 
β-Cyclodextrin (β-CD) is the most widely used natural cyclodextrin, 
which forms inclusion complexation with drug molecules and 
enhances solubility. From the previous studies it has been proved 
that with β-CD nanocomposites formation by solvent evaporation, 
the solubility of drugs can be enhanced significantly [10, 11]. 
The surfactants can be employed in pharmaceutical dosage forms as 
a solubilizer, emulsifier, wetting agent, suspending agent, detergent, 
etc. Gelucire 48/16 is a novel hydrophilic grade of polymer, 
extensively used to enhance solubility and bioavailability of the 
drug. We have used gelucire 48/16 along with Soluplus to prepare 
ternary solid dispersion [12]. 
Solid dispersion prepared by the solvent evaporation method has 
been proved to enhance the solubility of drugs successfully. Ternary 
solid dispersions were developed using different polymers like 
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soluplus, kolliphor P188, affinisol, sylloid 244 FP, gelucire 48/16, 
etc. In this drug and carrier were dissolved in a volatile solvent with 
homogeneous mixing. The volatile solvent was later evaporated at 
normal room temperature [13]. 
The present research work was aimed to study and explore new 
combinations of polymers for solubility enhancement. NTG binary 
and ternary dispersions were prepared by the common solvent 
evaporation method for solubility and dissolution enhancement. 
Finally, the optimized dispersions were formulated as tablets. In 
vitro drug release through in house formulations and marketed 
tablets were studied. 
MATERIALS AND METHODS 
Materials 
The pharmaceutical grade of Nateglinide was obtained as a generous 
gift from Cipla Ltd. Goa, India. β Cyclodextrin and Hydroxypropyl β 
Cyclodextrin were purchased from Sigma Aldrich (Mumbai, India). 
Affinisol, soluplus, kolliphor P 188, gelucire 48/16, sylloid 244FP 
were provided as a gift sample by Lupin Ltd Aurangabad, India. 
Ethanol was purchased from Himedia Laboratories, Mumbai, India. 
All remaining ingredients were purchased from S. D Fine Chemicals 
(Mumbai, India).  
Solubility determination of nateglinide 
Nateglinide solubility was determined in different media like 
Phosphate buffer pH 6.8, Phosphate buffer pH 7.4, 0.1 N HCl, and 
reported dissolution media 0.5 % SLS in 0.01 N HCl. Binary and 
ternary complexes of NTG were formulated with polymers like 
soluplus, β-cyclodextrin and hydroxypropyl β-Cyclodextrin, and 
affinisol. The Solvent co-evaporation method was employed to 
prepare solid dispersions. The complexes were scraped and 
collected. Table 1. Shows the Composition of different binary and 
ternary SD. 
 
Table 1: Composition of different binary and ternary SD 
Dispersion type Combination Code Weight ratio 
Binary dispersion NTG and Soluplus F1 1:1 
NTG and Soluplus F2 1:2 
NTG and HPBCD F3 1:1 
NTG and HPBCD F4 1:2 
NTG and BCD F5 1:2 
NTG and BCD F6 1:3 
NTG and Affinisol F7 1:1 
NTG and Affinisol F8 1:2 
NTG and Affinisol F9 1:3 
NTG and KolliphorP188 F10 1:2 
Ternary dispersion NTG+Soluplus+Kolliphor P188  F11 1:1:1 
NTG+Soluplus+Affinisol F12 1:1:1 
NTG+Soluplus+Gelucire 48/16 F13 1:1:1 
NTG+BCD+Na2CO3 F14 1:1:1 
NTG+Soluplus+Sylloid FP244 F15 1:1:1 
 
Formulation of binary and ternary solid dispersions 
A weighed amount of nateglinide and polymer were mixed, dissolved 
in common solvent ethanol; the mixture was then sonicated for 10-20 
min using ultra-probe sonication Model Frontline Sonicator FS-250 
(Ahmedabad, India) to prepare the homogenous Solution later the 
solvent evaporated at room temperature. Nateglinide and polymers 
were dissolved in ethanol in different ratios (1:1,1:2, 1:3.1:4) to 
prepare SD by the solvent evaporation technique until we find the best 
proportion of drug and polymer. The prepared complexes were 
studied for solubility. In this same way, complexes were prepared with 
Soluplus, βCD, HPβCD, and Affinisol. Solubility for all prepared 
complexes was determined and the best ratios of the drug: polymer 
was decided. To formulate a ternary complex, a binary complex with 
the best solubility was selected and formulated. The combinations of 
polymers given in the following table 1. In the given ratio, the drug and 
polymers were dissolved in ethanol with continuous stirring and the 
solvent was evaporated at room temperature. Prepared complexes 
were then scraped and studied [14, 15]. The graphical abstract of the 
formulation is shown in fig. 1. 
  
 
Fig. 1: Formulation of ternary solid dispersions 
 
Determination of saturated solubility of NTG and prepared 
solid dispersions 
To determine the solubility of the Nateglinide pure drug and 
dispersions, an excess quantity of the drug or its dispersions 
equivalent to 50 mg nateglinide were added to a 10 ml Volumetric 
flask containing 5 ml of the 0.5% SLS in 0.01 N HCl (Dissolution 
media of Nateglinide), the vials were stirred at 100 RPM with a 
magnetic stirrer for 24 h, the aliquots were filtered through 0.45-
micron filter paper. The aliquots were diluted and assayed 
spectrophotometrically at 210 nm using a UV-Vis 
spectrophotometer (UV-1700 Pharmspec, Shimadzu, Kyoto, Japan). 
The calibration curve in different media was previously prepared for 
Nateglinide at 210 nm [16]. Similarly, Solubility of pure nateglinide 
is also determined in phosphate buffers pH 6.8, pH 7.4 and pH 1.2. 
Fourier transform infrared spectroscopy 
IR spectra of the pure NTG, all the formulated dispersion, were 
recorded on the FTIR spectrophotometer (Shimadzu 8400S, Japan) 
with KBr as the reference standard. FTIR study was conducted to 
study the alteration in the structure of pure NTG after the 
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formulation of ternary dispersions. FTIR determines drug-polymer 
compatibility. 2–3 mg samples were mixed with about 4 mg of 
potassium bromide, compressed through the manual press to form a 
thin disc. The IR spectra were recorded at a scanning range from 
4000–400 cm−1
Powder X-ray diffraction 
. 
The PXRD patterns of the pure nateglinide and the optimized NTG-
ternary dispersion were obtained using an X-ray diffractometer, 
Miniflex II (Regaku, USA). The samples were scanned in the range 
of 5 ° to 50 ° (diffraction angle 2θ), Cu K α line as the source of 
radiation with nickel filter, at the 40-kV voltage and 25-mA 
current.  
Differential scanning calorimetry 
DSC thermograms of pure NTG and the optimized NTG
Dissolution study of ternary dispersions 
-ternary 
dispersion were obtained by scanning from 10–400 °C at 10 °C/min 
with a differential scanning calorimeter (Mettler toledo, Japan). Each 
sample (approximately 5 mg) was weighed in a standard open 
aluminum pan using an empty pan as a reference. 
In vitro drug release through ternary solid dispersions and the pure 
drug (equivalent to 60 mg) was carried out in different Dissolution 
media, including 0.5% SLS in 0.01 N HCl, 0.1 N HCl, phosphate buffer 
having pH 6.8 and 7.4. Dissolution studies were carried out using the 
Electrolab USP II paddle apparatus at 37±0.5 °C in 1000 ml 
dissolution media; paddle speed was 50rpm, sampling was done at 
the time interval of 10, 20, 30 and 45 min. Aliquots were collected at 
different time intervals and filtered through a 0.45 μm filter. The 
fresh dissolution media was replaced again. The aliquots were 
subsequently diluted and the concentration of the drug was 
determined using a UV spectrophotometer at 210 nm.  
Tablet formulation 
After the solubility and dissolution study, the best ternary complexes 
were selected. For the best ternary complexes, tablets were 
formulated. For the formulation of a tablet karnavati tablet punching 
machine was used. For the prepared tablet dissolution, Disintegration, 
Hardness, Friability, Weight variation test was performed [17]. Table 2 
shows the composition of formulated tablets. 
  
Tablet 2: Formulation of NTG tablets 
S. No. Ingredient N1 Quantity (mg) N2 Quantity (mg) N3 Quantity (mg) 
1.  Nateglinide 60 60 60 
2.  Soluplus 60 60 60 
3.  Affinisol 60 - - 
4.  Kolliphor P188 - 60 - 
5.  Sylloid 244 FP   60 
6.  Avicel 102 36 36 36 
7.  Croscarmellose sodium 2 - - 
8.  Lactose - 20 - 
9.  Magnesium Stearate - 2 2 
10.  Talc 2 2 2 
The total weight (mg) 220 240 220 
 
Dissolution study of formulations 
For optimized formulations and marketed formulation dissolution 
study was performed in different dissolution media. All the 
parameters were kept similar to the dissolution study. The 
percentage of drug release from the optimized formulation and 
marketed formulation was calculated and compared. Sampling was 
done at the time interval of 10, 20, 30 and 45 min. The speed of the 
peddle was kept at 50 RPM. 
RESULTS AND DISCUSSION 
Saturation solubility of NTG 
Saturation solubility of NTG was determined in various media like 
reported dissolution media 0.5% SLS in 0.01N HCl, Phosphate buffer 
pH 6.8 and pH 7.4 and 0.1 N HCl. Values of Saturation solubility of 
NTG in various Dissolution media are given in the following table 3. 
Preliminary studies revealed that NTG is a poorly water-soluble 
drug and shows pH-dependent solubility at different physiological 
pH ranges. It was found that Solubility of NTG gradually increased 
from acidic pH to alkaline pH. 
Saturation solubility study of the prepared solid dispersions 
All the batches of the above Binary mixtures, ternary mixtures, and 
pure drugs were subjected to saturation solubility studies at room 
temperature in 0.5% SLS in 0.01N HCl, which is reported dissolution 
media for nateglinide. The amount of drug dissolved was analyzed 
by the UV-Vis spectroscopy at 210 nm. Nateglinide forms a very 
transparent solid solution after solvent evaporation with Soluplus 
and Affinisol. Saturation solubility study of NTG and all prepared 
dispersion was found as follows. Fold enhancement in solubility was 
calculated. Ternary solid dispersion of NTG with soluplus and 
kolliphor P188 shows the highest fold enhancement solubility. Table 
4. Shows saturation solubility data of nateglinide in various ternary 
dispersion.
  
Table 3: Saturation solubility data of nateglinide in various dissolution media: (mean±SD, n = 3) 
S. No. Nateglinide saturation solubility different media Solubility (mg/ml) 
1.  In 0.1 N HCl 0.525±0.027 
2.  In Phosphate buffer Ph 6.8 2.134±0.123 
3.  In Phosphate buffer Ph 7.4 6.864±0.145 
4.  In 0.5% SLS in 0.01 N HCl 2.856±0.032 
 
Fourier transform infrared spectroscopy (FT-IR) 
FT-IR is an important technique to predict a possible interaction of 
the drug with polymers in the solid-state. FT-IR spectroscopy was 
used to detect the presence of possible interactions between NTG, 
soluplus, affinisol, sylloid 244 FP, kolliphor P 188 that, if it should 
result in shifting of the absorption bands characteristic for 
functional groups, which is involved in the interaction.  
FT-IR spectra of NTG showed characteristic absorption peaks at 2927 
cm-1 (-OH stretching; asymmetric), 2866 cm-1 (aliphatic CH 
stretching; symmetric, 1741 cm-1 (C = O stretching), 3064 cm-1 
(aromatic C-H Stretching), 3300 cm-1 (aromatic N-H Stretching). The 
FTIR spectrum of ternary solid dispersions and pure glinide shows all 
the peaks for drug and other excipients, hence no interaction was 
observed between them. Considerable shifting of the major absorption 
bands of NTG has been observed in the spectra of all the analyzed 
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ternary formulations. On the spectrum of formulation F 11 (NTG: 
soluplus: kolliphor P 188), the sharp absorption peak of NTG, 
positioned at 2927 cm-1, changed to a broad absorption band positioned 
around 2883 cm-1, while the absorption band positioned at 1741 cm-1 
shifted to 1743 cm-1. In pure drug IR, N-H Stretching is observed at 3300 
cm-1, in the optimized ternary complexes showing the best solubility, 
almost disappearance of characteristic N-H stretching peak of NTG at 
3300 cm-1, this indicated the hydrogen bond interaction between NTG 
and Polymer complexes. In this case,–OH groups present in the NTG may 
be interacting with the terminal–OH and ether oxygen groups present in 
soluplus and form hydrogen bonds.  
Soluplus shows a characteristic peak at 1750 cm-1 and 1650 cm-1 
corresponding to the carbonyl–C = O group, 2747 and 2890 cm-1 
for–C-H, and broadband in the range 3200-3400 cm-1 representing 
the terminal–OH groups. The spectrum of Kolliphor P 188 is 
characterized by strong absorption peaks at 2880 cm–1 signifying 
the aliphatic–C-H stretch, 1339 cm–1 (in-plane O-H bend), and 1098 
cm–1 (C-O-stretch) Other absorption bands of NTG became 
indistinguishable. Formulation F 12 (NTG-soluplus-affinisol), and 
formulation F 15 (NTG-soluplus-sylloid 244), showed very similar IR 
spectra. Comparative graphs of some ternary dispersion are shown 
in the following fig. 2. 
 
Table 4: Saturation solubility data of nateglinide in 0.75% SLS (Reported dissolution media) (mean±SD, n = 3) 
Formulation code Combination Saturation solubility (mg/ml) Fold enhancement in solubility 
 NTG pure drug 2.85±0.032  
F1 NTG and Soluplus (1:1) 59.96±0.263 20.96 
F2 NTG and Soluplus(1:2) 57.26±0.127 20.02 
F3 NTG and HPBCD (1:1) 28.02±0.243 9.79 
F4 NTG and HPBCD(1:2) 30.18±0.115 10.55 
F5 NTG and BCD (1:2) 32.88±0.247 11.49 
F6 NTG and BCD(1:3) 35.90±0.362 12.55 
F7 NTG and Affinisol (1:1) 45.84±0.136 16.02 
F8 NTG and Affinisol(1:2) 42.24±0.261 14.76 
F9 NTG and Affinisol (1:3) 32.11±0.344 11.22 
F10 NTG and Kolliphor P188(1:1) 43.69±0.245 15.27 
F11 NTG+Soluplus+KolliphorP188 68.38±0.453 23.90 
F12 NTG+Soluplus+Affinisol 49.89±0.123 17.44 
F13 NTG+Soluplus+Gelucire 48/16 72.82±0.595 25.46 
F14 NTG+BCD+Na2CO3 38.57±0.183 13.48 
F15 NTG+Soluplus+Sylloid 244FP 48.86±0.496 17.08 
 
 
Fig. 2: Overley diagram of FTIR of pure nateglinide, NTG-soluplus-kolliphor, NTG-soluplus-gelucire, NTG-soluplus-sylloid ternary solid 
dispersions 
 
Powder X-ray diffraction 
The PXRD diffractograms of NTG and the optimized NTG-ternary 
dispersion are presented in fig. 3. As can be seen from the PXRD 
spectra of pure NTG, showed sharp characteristic diffraction peaks 
at 2θ diffraction angles of 5, 10.5, 12, 15 and 19 confirming the 
crystalline nature of the pure drug. In the PXRD spectra of optimized 
ternary solid dispersions, no characteristic peaks were observed. 
Broad hallows were observed, indicating the amorphous nature of 
NTG in ternary dispersions.  
Differential scanning calorimetry 
DSC thermograms of pure NTG and the optimized NTG-ternary 
dispersion are shown in fig. 4. The DSC curve of pure NTG exhibited 
a single endothermic peak at 130 °C, which indicates its melting 
point. Thus NTG exhibited in crystalline Form. The characteristic 
peak of the pure drug disappeared in the thermogram of ternary 
dispersions. This indicates a molecular dispersion of NTG in ternary 
dispersions. The total disappearance of the drug melting peak 
indicates the occurrence of the amorphous nature of NTG in ternary 
dispersions. The exothermic peak for the NTG-ternary dispersion 
was observed at 345.29 °C. 
Dissolution Study of dispersions 
Ternary dispersions with the highest solubility were selected and 
drug dissolution was studied through the selected combinations. 
The percentage of NTG release was calculated through all selected 
dispersion. The study was performed in different dissolution media. 
Table 5. Shows dissolution study of nateglinide ternary solid 
dispersions in different dissolution media (Percentage drug release) 
after 10 min of dissolution. 
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Fig. 3: PXRD thermogram of pure NTG and optimized ternary dispersion 
 
 
Fig. 4: DSC thermogram of pure NTG and optimized ternary dispersion 
 
Table 5: Dissolution study of nateglinide ternary solid dispersions in different dissolution media (Percentage drug release) after 10 min 
of dissolution 
Complexes Dissolution media 
0.5% SLS in 0.01 N HCl 0.1 N HCl Ph. 6.8 buffer Ph. 7.4 buffer 
Pure NTG 29.87 10.07 26.67 28.56 
NTG+Soluplus+KolliphorP188 100.89 100.54 89.54 94.67 
NTG+Soluplus+Affinisol 100.38 72.87 100.03 100.18 
NTG+Soluplus+Sylloid 98.89 100.35 93.53 95.67 
NTG+Soluplus+Gelucire 48/16 100.13 98.92 94.36 96.55 
NTG+BCD+Na2CO3 89.34 97.67 80.72 83.96s 
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NTG dissolution from solid dispersions 
The complexes showing more fold enhancement in solubility were 
selected and their dissolution study was performed in all selected 
media. Dissolution profiles of NTG from the pure drug were studied 
in dissolution media and percentage drug release through prepared 
formulations in all dissolution media, are shown in table 5. From the 
presented dissolution profiles, it can be observed that pure NTG 
dissolves slowly and incompletely, with less than 30 % of NTG 
dissolved after 45 min of testing. Dissolution of all prepared Ternary 
dispersions in 0.5% SLS in 0.01 N HCl, was faster relative to pure 
NTG. The fastest NTG dissolution rate was achieved from the 
formulation From complex ternary F13 (NTG+Soluplus+Gelucire 
48/16) 100.13% of the drug was released within 10 min of 
dissolution while from F11 (NTG+Soluplus+KolliphorP188), with 
100.89% of NTG dissolved after 20 min of Dissolution. F 12 
(NTG+Soluplus+Affinisol) dissolves 100.13% after 45 min. As all the 
prepared ternary dispersions were in powdered form, many were 
dissolved 100% within 10 min of dissolution. The percentage of 
drug release of all SD was very slow in 0.1 N HCl. All ternary 
dispersions prepared with soluplus were dissolved completely at all 
the dissolution media. Formulated combinations successfully 
enhanced the dissolution of NTG.  
Dissolution study of formulations 
Ternary dispersions showing improved drug release were 
formulated as NTG tablets. Dissolution study of optimized NTG 
tablets and marketed formulation, Glinate-60 was performed in 
different dissolution media. The comparative drug release was 
observed as follows. Table 6 shows comparative Percentage drug 
release from in house and marketed tablets in 0.5% SLS in 0.01% 
HCl dissolution media. Fig. 5 shows a Comparative percentage drug 
release from NTG marketed tablet and prepared tablets. 
 
Table 6: Percentage drug release of tablets in 0.5% SLS in 0.01% HCl dissolution media 
Time in min N1 N2 N3 Marketed brand glinate 60 
0 0 0 0 0 
10 59.57 33.67 49.28 63.79 
20 89.54 50.45 61.33 82.42 
30 100.17 78.34 77.86 100.32 
45 92.28 100.89 100.65 88.39 
 
 
Fig. 5: Comparative percentage drug release from NTG marketed tablet and prepared tablets 
 
DISCUSSION 
After solubility and dissolution determination of binary solid 
dispersions, we found that with all selected polymers, the solubility 
of the drug increases up to a certain limit beyond that it remains the 
same. Soluplus forms a solid solution with drugs that allows the drug 
in a dissolved state and shows superior performance to enhance 
solubility. NTG with soluplus shows more solubility at 1:1 ratio and 
solubility decreases with increasing concentration of soluplus. This 
might be due to Higher concentration may result in a cloudy or 
turbid aqueous solution. This is due to the formation of colloidal 
soluplus micelles. Molecular dispersion might be the reason behind 
the enhanced solubility of drugs with soluplus. By considering the 
size of the dosage form, we have considered 1:1 as a good ratio to 
make formulation. 
In ternary dispersions, NTG-Soluplus-KolliphorP188 combination 
enhanced solubility dramatically. Ternary dispersion with kolliphor 
P188 and soluplus, enhanced solubility of NTG Synergistically [18]. 
Another mechanism involved may be that, soluplus being 
hydrophilic makes a wet layer around the drug molecule which 
allows the transfer of solvent to the surface of the drug molecule 
which makes the drug molecule solubilize [19]. 
NTG-Soluplus-Gelucire 48/16 ternary combination was proved best. 
This combination enhanced the solubility of NTG by 25.46 fold. 
Gelucire 48/16 is a non-ionic surfactant proved as a solubilizer as 
well as a bioavailability enhancer. This polymer forms micelle 
solution with aqueous media, it enhances the wettability of the drug 
thereby improves solubility.  
CONCLUSION 
In the present investigation, there was a significant improvement in 
the solubility and dissolution profile of NTG by formulating ternary 
solid dispersions. Ternary solid dispersions prepared by the 
common solvent evaporation method proved a successful method to 
enhance the solubility of NTG. Solubility and dissolution were 
enhanced significantly with soluplus and kolliphor P188. Soluplus 
and gelucire 48/16 with NTG enhanced solubility dramatically. F11 
and F13 ternary dispersions were having the best solubility. 
Prepared tablets show very good dissolution. All formulations N1, 
N2, N3 showed the complete drug release after 45 min. Among all 
prepared formulations N1 was found best. 100 % Drug was released 
from the marketed tablet and N1 after 30 min. Formulating ternary 
solid dispersions of NTG with Soluplus and Kolliphor could be a 
potential strategy to improve the solubility of NTG.  
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